Research, remedy and regulation: the changing dynamics of psychedelic therapy in Alberta – CBC

There is a growing interest in the use of psychedelics for mental health treatment

Oct 24, 2022

Earlier this month, in the last days of the Jason Kenney government, Alberta announced the first provincial regulations for psychedelic-assisted therapy.

There is growing interest into the potential of psychedelics for mental health treatment with studies popping up all over the world and in Canada.

Psychedelic drugs as defined by the province include psilocybin (the active ingredient in magic mushrooms), MDMA (an amphetamine also called ecstasy or molly), mescaline (peyote) and ketamine.

Alberta’s new regulations would require the providers to apply for a licence before treating patients with psychedelics for mental health disorders. A psychiatrist would have to oversee any treatment, according to the regulations taking effect in January.

Read more:

NationTalk Partners & Sponsors Learn More